Zhejiang Jingxin Pharmaceutical Co., Ltd.

Sümbol: 002020.SZ

SHZ

12.29

CNY

Turuhind täna

16.3059
P/E suhe
-1.6917
PEG suhe
10.58B
MRK Cap
0.02%
DIV tootlus

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020-SZ) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 1492.149 M, mis on 0.147 % gowth. Kogu perioodi keskmine brutokasum on 767.696 M, mis on 0.182 %. Keskmine brutokasumi suhtarv on 0.402 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.065 %, mis on võrdne -0.361 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Zhejiang Jingxin Pharmaceutical Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.085. Käibevara valdkonnas on 002020.SZ aruandlusvaluutas 3353.735. Märkimisväärne osa neist varadest, täpsemalt 2019.93, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.055%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 1471.13, kui neid on, aruandlusvaluutas. See näitab erinevust 571.958% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 31.228 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 1.202%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 5512.374 aruandlusvaluutas. Selle aspekti aastane muutus on 0.071%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 664.015, varude hind on 652.69 ja firmaväärtus 348.48, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 401.26.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
balance-sheet.row.cash-and-short-term-investments	7335.53	2019.9	1915.4	1977.2	2094.2	2441.6	410.9	333.5	261.7	432.6	380.1	197.5	313	322	102.3	222.8	227.6	228.7	106.6	68	77.7	22	15.1	4.3
balance-sheet.row.short-term-investments	1127.56	609.3	366.9	422.4	1178.8	1948.4	-164.3	-128.3	-125.5	-152.3	-140.7	0	0.1	0.1	0	0	0	0	3.4	0	0	0	0	0
balance-sheet.row.net-receivables	2431.47	664	570	586.7	444.3	524.1	561	709.7	416	368.4	232.3	201.3	157.1	123.1	241.9	134.5	139.5	175.9	93.9	112.5	122	88	59.4	49.9
balance-sheet.row.inventory	2703.54	652.7	773.7	649.1	500.8	416.4	362.6	296.1	253.9	251.9	179	165.9	165.7	136.3	132	84.4	91.1	123.4	130.7	65.2	61	35.2	43.9	57.1
balance-sheet.row.other-current-assets	299.73	17.1	22.1	16.5	85.7	103	1701.1	1656.7	631.3	380.3	348.1	-7.9	-10.1	-8	-9.6	-14.3	-19.8	-22.3	-11.5	-4.5	-5.4	-3.1	-4.2	5
balance-sheet.row.total-current-assets	12770.27	3353.7	3281.2	3229.5	3125	3485.2	3035.5	2996	1562.9	1433.3	1139.6	556.7	625.6	573.4	466.7	427.4	438.5	505.8	319.7	241.1	255.3	142.1	114.1	116.3
balance-sheet.row.property-plant-equipment-net	8656.05	2309.8	1632.1	1262.9	1078.8	962.4	817.1	731.9	705.4	664.4	614.1	510.8	413.2	463.7	337.9	344.5	399.2	386.6	373.6	250.4	137	91.3	48.5	28.3
balance-sheet.row.goodwill	1393.94	348.5	348.5	257.9	257.9	257.9	257.9	257.9	414.4	423.4	0	0	0	0	0	0	0.5	0.5	0.5	0	0	0	0	0
balance-sheet.row.intangible-assets	1617.31	401.3	418.6	137.7	150.8	166.6	141.2	157.9	174.4	190.6	108.4	114.2	120.1	88.5	90.5	92	102	104.2	75.7	72	68.9	21.8	19.3	7.9
balance-sheet.row.goodwill-and-intangible-assets	3011.25	749.7	767.1	395.6	408.7	424.5	399.1	415.8	588.8	614	108.4	114.2	120.1	88.5	90.5	92	102.5	104.7	75.7	72	68.9	21.8	19.3	7.9
balance-sheet.row.long-term-investments	2754.28	1471.1	218.9	119.5	-631.5	-1502	694.6	726.6	405.2	210.4	190.7	0	0	0	0	0	0	0	0.5	0	0	0	0	0
balance-sheet.row.tax-assets	297.88	81	75.1	62.5	44	48.6	37.1	23.7	18.9	17.1	7.2	4.8	4.9	5.5	3	1.7	4.8	6.7	3.5	0	0	0	0	0
balance-sheet.row.other-non-current-assets	4007.56	21.2	1388.1	1345.3	1641.3	2206.4	8.2	9.8	9.4	0.7	4.7	138.1	137.1	61.5	51.1	51.6	8.2	11.9	0	5.3	3.9	3.6	0.4	0
balance-sheet.row.total-non-current-assets	18727.02	4632.8	4081.4	3185.8	2541.2	2139.9	1956.2	1908	1727.7	1506.6	925.1	767.9	675.4	619.1	482.5	489.8	514.6	510	453.2	327.8	209.8	116.7	68.2	36.2
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	31497.29	7986.6	7362.6	6415.4	5666.2	5625.1	4991.8	4904	3290.6	2939.9	2064.7	1324.6	1301	1192.6	949.1	917.2	953.1	1015.8	772.8	568.9	465.1	258.8	182.4	152.5
balance-sheet.row.account-payables	3316.2	610.8	719.1	435.1	369.1	456.6	422	368.3	317	316.2	403.1	245.4	211.1	111.8	179.6	244	208.5	260.9	187.2	110.1	92.2	59	32.6	38.1
balance-sheet.row.short-term-debt	1704.65	621.3	253.3	161.9	300.1	358.5	150	0	200	51.8	39.2	124.4	203.3	215.6	234.6	247.3	378	230	211.5	132.1	27	60	41.8	34.8
balance-sheet.row.tax-payables	199.19	44.3	105.4	95	93.4	88.3	98.4	101.1	50	50.1	22.4	6.4	3.5	2.6	0.6	4.3	5.2	0.2	-1.4	1.5	4.1	3.3	2.4	4.4
balance-sheet.row.long-term-debt-total	139.56	31.2	43	6.6	0.6	0.9	0	0	0	0	0	11.6	23.2	49.8	149.4	65	20	160	20	0	38.1	30.1	20	0
Deferred Revenue Non Current	1091.72	268.8	270.6	128.7	138.7	122.3	70	65.2	62.3	58.8	59.3	42.1	0	0	0	-61.4	-20	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	254.92	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	805.52	789.3	761.9	4.7	4.9	55.8	670.6	501.1	23.1	19.9	8.5	13.7	11.1	9.6	8.5	3.7	2.5	3	11.7	10	6.7	2.6	11.3	24.7
balance-sheet.row.total-non-current-liabilities	1227.33	102.8	375.2	192.6	186.7	144.1	77.4	69	65.9	62.4	62.1	52.6	67.8	70.9	171.8	69.9	20.9	179.1	49.4	1	39.1	31.1	21.1	1
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	139.56	31.2	43	6.5	17.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	9357.68	2177.6	2190.6	1577.7	1733.6	1914.4	1418.4	938.4	864.2	679.4	666.1	506.7	528.4	426.4	629	610.1	649.9	716.2	478.2	279.3	181.1	170.4	119.4	111.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	3444.12	861	861	905.3	705.5	724.9	724.9	736.1	639.2	319.6	286.5	252.7	126.3	126.3	101.5	101.5	101.5	101.5	101.5	67.7	67.7	50.1	50.1	30
balance-sheet.row.retained-earnings	9981.01	2540.1	2228.8	1871.1	1554.6	1187.4	843.1	642.2	478.4	334	218.1	140.3	98	93.3	66.1	53.6	50.5	69.7	64.9	55.1	52.6	30.6	9	2.4
balance-sheet.row.accumulated-other-comprehensive-income-loss	4893.06	388	336.1	285.9	218.2	162.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	3443.45	1723.3	1720.2	1755.1	1439.3	1620.9	1993.8	2542.3	1263.5	1563.3	894	425	548.2	546.5	148.3	147.9	147.3	126.9	126.7	159.8	159.3	7.7	3.9	8.3
balance-sheet.row.total-stockholders-equity	21761.63	5512.4	5146.1	4817.4	3917.6	3696.1	3561.8	3920.6	2381	2216.9	1398.5	818	772.6	766.2	315.9	303	299.3	298.2	293.1	282.6	279.5	88.4	63	40.7
balance-sheet.row.total-liabilities-and-stockholders-equity	31497.29	7986.6	7362.6	6415.4	5666.2	5625.1	4991.8	4904	3290.6	2939.9	2064.7	1324.6	1301	1192.6	949.1	917.2	953.1	1015.8	772.8	568.9	465.1	258.8	182.4	152.5
balance-sheet.row.minority-interest	109.17	27.8	25.8	20.2	15.1	14.6	11.6	44.9	45.4	43.6	0	0	0	0	4.2	4.1	3.9	1.4	1.5	7	4.5	0	0	0
balance-sheet.row.total-equity	21870.8	5540.2	5172	4837.7	3932.7	3710.7	3573.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	31497.29	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	3881.85	2080.4	585.8	541.9	547.3	446.4	530.3	598.3	279.7	58.1	50	0	0.1	0.1	0	0	8	11.6	3.9	3.6	3.6	3.6	0.1	0
balance-sheet.row.total-debt	1844.21	652.5	296.3	168.5	300.8	359.4	150	0	200	51.8	39.2	136	226.4	265.4	384	312.3	398	390	231.5	132.1	65.1	90.1	61.8	34.8
balance-sheet.row.net-debt	-4363.76	-758.2	-1252.2	-1386.3	-614.6	-133.8	-260.9	-333.5	-61.7	-380.8	-341	-61.4	-86.5	-56.5	281.6	89.5	170.4	161.3	124.9	64.1	-12.6	68.1	46.7	30.5

Rahavoogude aruanne

Zhejiang Jingxin Pharmaceutical Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab -0.103 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab 0.000 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -769446156.000. See on 0.043 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 221.47, 0, -35, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -258.31 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -3.97, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
cash-flows.row.net-income	638.91	618.9	667.8	614.7	653.3	521.9	371.5	267	216.7	166.6	107.1	64.3	31.7	29.1	13	4	-18.3	1.5	10.5	18.5	25.8	25.4	22.3
cash-flows.row.depreciation-and-amortization	10.99	221.5	166.9	143.6	123.2	106.2	90.6	86.7	80	58.9	50.6	42.4	41	39	38.2	38.8	37.4	28.1	23	13.4	8.5	5.7	0
cash-flows.row.deferred-income-tax	0	2.8	-12.2	-5.8	31	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	-488	12.2	5.8	-31	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	29.56	-45	21.3	-391.7	-120.9	-42.3	97.5	-137.1	-60.8	-74.8	51.2	-12.4	-32.1	-17.3	-14.3	73.6	-24.4	-137.9	-6.4	26.2	-32.2	9.9	0
cash-flows.row.account-receivables	-93.48	-93.5	-250.9	-208.6	34.4	-170.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	123.04	123	-103	-147.8	-82.7	-60.1	-68.7	-44.7	-2.8	-73.4	-12.6	-5.7	-28.8	-5.1	-47.8	9.6	29.2	7.3	-65.5	-4.2	-25.7	8.6	0
cash-flows.row.account-payables	0	-74.6	387.4	-41.8	-103.7	188.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	0	-12.2	6.5	31	-0.1	166.3	-92.3	-58	-1.3	63.7	-6.8	-3.3	-12.3	33.6	64	-53.5	-145.2	59.1	30.4	-6.5	1.3	0
cash-flows.row.other-non-cash-items	275.34	514.5	-0.3	-1.5	-142.4	-50.6	-36.2	168.3	16.8	-6	1.6	16.7	19.7	18.6	22.6	19.1	35.2	20.7	-28.6	3.7	4.3	5.2	-22.3
cash-flows.row.net-cash-provided-by-operating-activities	954.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-339.78	-519.5	-515.6	-404.4	-334	-337.3	-242.2	-112.2	-95.3	-114.3	-94.7	-108.3	-83.5	-71.9	-155.9	-20.2	-43.8	-54.8	-91.3	-134.7	-98.1	-71.2	-47.8
cash-flows.row.acquisitions-net	9.85	10.3	5.2	8.3	2.4	-1.9	0	115.8	-31.5	-259.1	0.5	0	0	0	0	0	0	-1.7	91.9	0	0	0	0
cash-flows.row.purchases-of-investments	-870.2	-1175.2	-1058	-861.7	-2170	-2145	-2853.3	-2231.9	-847.8	-430.8	-398	0	0	-24.2	0	0	0	-8	-6	0	0	-3.5	-0.1
cash-flows.row.sales-maturities-of-investments	1011.18	915	833.9	1407.9	2978	2267.5	2920.5	1039.5	543.9	487.5	0.6	0	0	0	0	17.1	17.3	57.8	0.1	0	0	0	0
cash-flows.row.other-investing-activites	311.97	0	-3.2	-5.3	-12.5	2.5	2.8	-112.2	6.9	0.3	-0.9	1.6	0.9	7.2	9.9	0.7	15.1	9.4	-91.3	1.6	0	0	2.4
cash-flows.row.net-cash-used-for-investing-activites	-189.34	-769.4	-737.7	144.7	463.9	-214.2	-172.2	-1301	-423.7	-316.4	-492.5	-106.7	-82.6	-88.8	-145.9	-2.4	-11.5	2.7	-96.6	-133	-98.1	-74.7	-45.5
cash-flows.row.debt-repayment	-339.22	-35	-150	-300.3	-358.8	-155	0	-130	-370.9	-162	-393.7	-724.2	-757.6	-435	-236.3	-498	-333	-268.5	-249.6	-27	-128	-86.7	-81.8
cash-flows.row.common-stock-issued	0	0	0	0	201	49.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	-201	-235.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-258.11	-258.3	-258.6	-232.2	-235.4	-206.9	-142.8	-64	-49.8	-50.3	-30.4	-32	-41.5	-22.5	-18.6	-23.6	-38.5	-17.6	-11.5	-18.7	-5	-4.8	-4
cash-flows.row.other-financing-activites	593.64	-4	220.5	653.3	96.8	321.8	-135.2	1187.3	509.3	440.4	795.5	689.6	678.5	739.4	317.4	412.3	330.4	395.2	365.6	95.8	276	117	109.1
cash-flows.row.net-cash-used-provided-by-financing-activities	-180.91	-245.6	-188	120.8	-497.4	-226.3	-278	993.3	88.5	228.1	371.4	-66.5	-120.5	281.9	62.5	-109.3	-41.1	109	104.5	50.2	143	25.6	23.3
cash-flows.row.effect-of-forex-changes-on-cash	5.78	2.7	14.9	-3.8	-9.9	1.8	3.3	-5.6	3.4	3.8	0.1	-1	-0.4	-0.8	-1.4	-0.3	-0.1	-1.1	-0.4	-0.4	-0.2	0	0
cash-flows.row.net-change-in-cash	684.27	-77.8	-55	626.8	469.8	96.5	76.5	71.7	-79.1	60.1	89.5	-63.2	-143.2	261.7	-25.3	23.4	-22.7	23	6	-21.5	51.2	-3	23.3
cash-flows.row.cash-at-end-of-period	5962.04	1410.6	1463.7	1512.8	886	416.2	319.4	242.9	171.2	250.3	190.1	100.6	163.8	307	45.3	70.7	47.3	70	47	41	62.5	11.3	23.3
cash-flows.row.cash-at-beginning-of-period	5277.77	1488.5	1518.7	886	416.2	319.7	242.9	171.2	250.3	190.1	100.6	163.8	307	45.3	70.7	47.3	70	47	41	62.5	11.3	14.3	0
cash-flows.row.operating-cash-flow	954.8	824.7	855.8	365	513.2	535.3	523.4	385	252.7	144.7	210.5	111	60.3	69.4	59.5	135.4	30	-87.6	-1.4	61.8	6.4	46.2	45.5
cash-flows.row.capital-expenditure	-339.78	-519.5	-515.6	-404.4	-334	-337.3	-242.2	-112.2	-95.3	-114.3	-94.7	-108.3	-83.5	-71.9	-155.9	-20.2	-43.8	-54.8	-91.3	-134.7	-98.1	-71.2	-47.8
cash-flows.row.free-cash-flow	615.02	305.2	340.2	-39.4	179.2	198	281.2	272.8	157.4	30.4	115.7	2.8	-23.2	-2.4	-96.3	115.2	-13.8	-142.4	-92.7	-72.9	-91.7	-25	-2.3

Kasumiaruande rida

Zhejiang Jingxin Pharmaceutical Co., Ltd. tulud muutusid võrreldes eelmise perioodiga 0.046%. 002020.SZ brutokasum on teatatud 1903.77. Ettevõtte tegevuskulud on 1324.59, mille muutus võrreldes eelmise aastaga on -2.201%. Kulud amortisatsioonikulud on 221.47, mis on 0.211% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 1324.59, mis näitab -2.201% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -0.235% kasvu võrreldes eelmise aastaga. Tegevustulu on 579.19, mis näitab -0.235% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.065%. Eelmise aasta puhaskasum oli 618.9.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
income-statement-row.row.total-revenue	4082.46	3952.1	3779.8	3336	3258.1	3646.7	2943.8	2219.1	1875.5	1415.7	1235.5	974.4	857.6	709.7	631	531.5	510.3	565.2	428.9	301.9	348.2	301.5	270	227.1
income-statement-row.row.cost-of-revenue	2026.66	2048.3	1766.1	1472.8	1273.3	1273.4	1034.7	911.9	864.4	698.7	659.8	574.4	559.6	522.4	442.4	367.3	361.3	439	310.7	204.6	261.4	220.8	208.9	185.9
income-statement-row.row.gross-profit	2055.8	1903.8	2013.7	1863.2	1984.7	2373.3	1909.1	1307.1	1011.1	717	575.7	400	298	187.3	188.6	164.2	149	126.2	118.1	97.3	86.8	80.7	61.1	41.1
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	410.79	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	78.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	790.89	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-21.94	6.4	135.7	99.8	114.7	172.1	-0.9	231.9	19.4	13	4.8	12.7	5	7	4.5	4.5	10.1	12.1	2.9	-5.9	2.6	0.7	2.7	1
income-statement-row.row.operating-expenses	1442.43	1324.6	1354.4	1250.3	1411.4	1836.6	1537.2	1029.5	769.8	555.2	456.8	326.6	250.1	137.3	157.5	143.6	134.2	111.2	91	61.3	50.7	44.5	32.4	25.6
income-statement-row.row.cost-and-expenses	3469.09	3372.9	3120.5	2723	2684.7	3110.1	2571.9	1941.4	1634.2	1254	1116.5	901	809.7	659.8	599.9	510.9	495.5	550.3	401.7	265.9	312.1	265.3	241.3	211.5
income-statement-row.row.interest-income	43.91	60.3	65.6	48.1	20.1	7.4	2	4.1	6.4	12.7	8	8	7.9	2.3	2	6.4	8.7	3.1	1.2	0.7	1.5	0.4	0.3	1.1
income-statement-row.row.interest-expense	6.56	7.3	6	3.7	6	10.6	5.1	0.1	8.2	7.3	5.5	13.4	16.2	22.1	19	23.4	38.1	22.5	11.8	5.3	4.9	4.5	3.7	4
income-statement-row.row.selling-and-marketing-expenses	790.89	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	77.27	134.9	-6.3	1.5	-6.4	1.4	43.5	73	14	35	7.9	2.3	-8	-13.3	-16.7	-12.2	-25.1	-12.8	-10.4	-11.6	-1.2	-3.6	-1	-0.5
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-21.94	6.4	135.7	99.8	114.7	172.1	-0.9	231.9	19.4	13	4.8	12.7	5	7	4.5	4.5	10.1	12.1	2.9	-5.9	2.6	0.7	2.7	1
income-statement-row.row.total-operating-expenses	77.27	134.9	-6.3	1.5	-6.4	1.4	43.5	73	14	35	7.9	2.3	-8	-13.3	-16.7	-12.2	-25.1	-12.8	-10.4	-11.6	-1.2	-3.6	-1	-0.5
income-statement-row.row.interest-expense	6.56	7.3	6	3.7	6	10.6	5.1	0.1	8.2	7.3	5.5	13.4	16.2	22.1	19	23.4	38.1	22.5	11.8	5.3	4.9	4.5	3.7	4
income-statement-row.row.depreciation-and-amortization	82.38	221.5	182.9	170.6	115.7	129	90.6	86.7	80	58.9	50.6	42.4	41	39	38.2	38.8	37.4	28.1	23	13.4	8.5	5.7	6.1	4.6
income-statement-row.row.ebitda-caps	740.39	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	658.01	579.2	756.6	693	765.4	602.1	416.3	118.7	236.3	186.1	124.4	63	36.3	29.7	9.9	3.9	-20.3	-10	15.8	30.9	32.3	32	25.6	14.8
income-statement-row.row.income-before-tax	735.28	714.1	750.3	694.5	759	603.4	415.4	350.7	255.3	196.7	126.9	75.7	39.9	36.7	14.4	8.4	-10.3	2.1	17.7	24.7	34.9	32.6	28	15.4
income-statement-row.row.income-tax-expense	90.4	84.6	82.5	79.8	105.7	81.5	44	83.6	38.6	30.1	19.8	11.4	8.2	7.6	1.5	4.4	8	0.7	7.3	6.2	9.1	7.2	5.7	5.4
income-statement-row.row.net-income	638.91	618.9	662.3	612.5	653.1	520.4	370	264.4	211.9	165.2	107.1	64.3	31.7	29.1	12.9	3.8	-17.7	1.5	10.5	18.5	25.8	25.4	22.3	10